UK-Based Named Patient
Medicine Supply
for Hospitals & Institutions
Euro Biom is an MHRA WDA-licensed pharmaceutical wholesaler specialising in the sourcing and supply of unlicensed and named patient medicines to hospitals, procurement teams and NGOs in the UK and internationally.
⚡ Same-day response to every enquiry · Mon-Fri 09:00-18:00 · WhatsApp us
alternative exists.
A named patient medicine is an unlicensed medicine supplied for an identified patient when no licensed product is available or clinically appropriate. In the UK, this is permitted under Regulation 167 of the Human Medicines Regulations 2012.
The prescribing doctor takes clinical responsibility for the decision to use the unlicensed product. The supplier, Euro Biom, takes responsibility for sourcing from authorised manufacturers, maintaining the cold chain, and providing complete GDP-compliant documentation.
This service is also used internationally, where a medicine is registered in the UK but not in the destination country, or where the patient requires a specific formulation, strength or presentation unavailable locally.
and Clinical Procurement
Named patient supply is used by a wide range of healthcare buyers. If your conventional supplier cannot source what you need, we can.
The licences that make
this supply legal and traceable.
Named patient supply must be handled by an MHRA-licensed Wholesale Dealer. Euro Biom holds the correct authorisations to source, handle and export unlicensed medicines compliantly.
MHRA Wholesale Dealer Authorisation
Euro Biom holds WDA(H) 59239, granted by the Medicines and Healthcare products Regulatory Agency on 17 March 2026. This authorisation is publicly verifiable on the MHRA register.
GDP Good Distribution Practice
All products are handled in accordance with UK Good Distribution Practice guidelines. Every shipment includes a complete chain-of-custody record, temperature monitoring where required, and batch-level documentation from manufacturer to recipient.
Regulation 167, Human Medicines Regulations 2012
UK legislation permits the supply of unlicensed medicines to meet individual patient needs where no licensed alternative is suitable. Euro Biom operates within this framework, supplying only on the basis of a prescriber's clinical decision and documented patient need.
International Export
Our WDA authorises export of named patient medicines to countries worldwide. We prepare all UK export documentation including Certificates of Free Sale, and can advise on import requirements for GCC, African and Asian markets based on our operational experience.
Step by Step
Our process is designed to be fast, clear and fully compliant at every stage.
Named patient requirements arise most frequently in specialty and rare disease medicine. Euro Biom has experience across all of the following therapeutic categories.
for the fastest response.
The more detail you provide upfront, the faster we can assess sourcing options and respond with availability and lead times. None of these fields are mandatory to start, but each one speeds up the process.
Submit a Named Patient Enquiry →⚡ Same-day response · WhatsApp us directly
Ready to Submit a Named Patient Enquiry?
Tell us what you need. We respond the same working day with sourcing options, availability and lead times. No commitment required at enquiry stage.
Common questions from hospital pharmacists, procurement managers and international buyers.
Further reading for hospital pharmacists and procurement teams.